SCHEMBL6196017

SCHEMBL6196017

CCc1ccc(NC(=O)NC2CCN(CCNC(=O)Nc3cc(C)nc4ccccc34)C2)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 4/20 0.56
ADRA2A P08913 1/20 0.56
DRD2 P14416 1/20 0.56
SLC6A2 P23975 1/20 0.56
HTR2A P28223 1/20 0.56
HTR2C P28335 1/20 0.56
SLC6A4 P31645 1/20 0.56
TMEM97 Q5BJF2 1/20 0.56
SIGMAR1 Q99720 1/20 0.56
POLB P06746 1/20 0.47
MEN1 O00255 1/20 0.47
TP53 P04637 1/20 0.47
ALOX15 P16050 1/20 0.47
KMT2A Q03164 1/20 0.47
IGF1R P08069 2/20 0.47
CCR3 P51677 1/20 0.46
CXCR3 P49682 1/20 0.44
EPHX2 P34913 1/20 0.44
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6193137 0.95 UTS2R (0.60) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6196121 0.93 UTS2R (0.56) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6201161 0.91 UTS2R (0.55) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6195133 0.91 UTS2R (0.55) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6197465 0.91 UTS2R (0.55) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6198104 0.90 UTS2R (0.53) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6195643 0.90 UTS2R (0.53) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6195430 0.90 IGF1R (0.61) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6196245 0.90 CXCR3 (0.55) UTS2RADRA2ADRD2SLC6A2HTR2A
SCHEMBL6197129 0.88 UTS2R (0.59) UTS2RADRA2ADRD2SLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499607-B1 4-(PIPERIDYL- AND PYRROLIDYL-ALKYL-UREIDO)-QUINOLINES AS UROTENSIN II RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2005-12-07 EP disclosed